Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Albert W. H. Neitz"'
Autor:
Albert W. H. Neitz, Mohammed Auwal Ibrahim, June C. Serem, Anabella R.M. Gaspar, Megan Jean Bester
Publikováno v:
International Journal of Peptide Research and Therapeutics. 26:1949-1963
Type 2 diabetes mellitus (T2DM) is a multifactorial disease that requires multiple therapeutic strategies for its management. Bioactive peptides with multiple anti-diabetic targets are attractive therapeutic molecules. The present study was conducted
Publikováno v:
Biomedicine & Pharmacotherapy. 107:234-242
Treatment of type 2 diabetes is achieved through the inhibition of carbohydrate hydrolyzing enzymes such as α-glucosidase and α-amylase. The present study was conducted to identify novel α-glucosidase inhibitory peptides and to validate the α-glu
Publikováno v:
International Journal of Peptide Research and Therapeutics. 25:437-446
In silico analysis was used to evaluate storage proteins from plant tubers as potential precursors of bioactive peptides after simulated gastrointestinal digestion. Proteins derived from potato (patatins), sweet potato (sporamins), yam (dioscorins) a
Autor:
Megan Jean Bester, Yasien Sayed, Adam A. Strömstedt, Clerisa Odendaal, Anabella R.M. Gaspar, Albert W. H. Neitz, June C. Serem, Naadhira O. Ismail
Publikováno v:
Journal of Peptide Science. 25
Previously Os, a 22 amino acid sequence of a defensin from the soft tick Ornithodoros savignyi, was found to kill Gram-positive and Gram-negative bacteria at low micromolar concentrations. In this study, we evaluated synthetic peptide analogues of Os
Autor:
Megan Jean Bester, Mohammed Auwal Ibrahim, Albert W. H. Neitz, Anabella R.M. Gaspar, June C. Serem
Publikováno v:
Protein and peptide letters. 26(6)
Background: Peptide-based therapeutics offer a unique avenue for the development of novel agents for the treatment of diabetes mellitus including α-glucosidase inhibitors. The peptide, SQSPA, was reported to possess to α -glucosidase inhibitory act
Publikováno v:
Journal of Peptide Science. 22:43-51
Antimicrobial peptides are small cationic peptides that possess a large spectrum of bioactivities, including antimicrobial, anti-inflammatory and antioxidant activities. Several antimicrobial peptides are known to inhibit lipopolysaccharide (LPS)-ind
Autor:
Anabella R.M. Gaspar, Albert W. H. Neitz, Mohammed Auwal Ibrahim, Megan Jean Bester, June C. Serem
Publikováno v:
International journal of biological macromolecules. 122
Antidiabetic agents with multiple targets have the greatest pharmaceutical potential. In this study, three α-glucosidase inhibitory peptides, PFP, YPL and YPG, were investigated for additional antidiabetic targets viz.; dipeptidyl peptidase-IV inhib
Publikováno v:
Veterinary Sciences
In comparison to other arachnids, ticks are major vectors of disease, but less than 8% of the known species are capable of inducing paralysis, as compared to the ~99–100% arachnids that belong to venomous classes. When considering the potential mon
Publikováno v:
Peptides. 71:179-187
Os and Os-C are two novel antimicrobial peptides, derived from a tick defensin, which have been shown to have a larger range of antimicrobial activity than the parent peptide, OsDef2. The aim of this study was to determine whether the peptides Os and
Publikováno v:
Chemical biologydrug design. 91(2)
Bioactive peptides are emerging as promising class of drugs that could serve as α-glucosidase inhibitors for the treatment of type 2 diabetes. This article identifies structural and physicochemical requirements for the design of therapeutically rele